Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease. 1982

P Amair, and R Khanna, and B Leibel, and A Pierratos, and S Vas, and E Meema, and G Blair, and L Chisolm, and M Vas, and W Zingg, and G Digenis, and D Oreopoulos

Twenty diabetics with end-stage renal disease who had never previously received dialysis treatment were treated with continuous ambulatory peritoneal dialysis for periods of two to 36 months (average, 14.5). Intraperitoneal administration of insulin achieved good control of blood sugar. Even though creatinine clearance decreased significantly (P = 0.001), control of blood urea nitrogen and serum creatinine was adequate. Hemoglobin and serum albumin levels increased significantly (P = 0.005 and 0.04, respectively). Similarly, there was a significant increase in serum triglycerides and alkaline phosphatase (P = 0.02 and 0.05). Blood pressure became normal without medications in all but one of the patients. Retinopathy, neuropathy, and osteodystrophy remained unchanged. Peritonitis developed once in every 20.6 patient-months--a rate similar to that observed in nondiabetics. The calculated survival rate was 93 per cent at one year; the calculated rate of continuation on ambulatory peritoneal dialysis was 87 per cent. We conclude that continuous ambulatory dialysis with intraperitoneal administration of insulin is a good alternative treatment for diabetics with end-stage renal disease.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson

Related Publications

P Amair, and R Khanna, and B Leibel, and A Pierratos, and S Vas, and E Meema, and G Blair, and L Chisolm, and M Vas, and W Zingg, and G Digenis, and D Oreopoulos
October 1982, The New England journal of medicine,
P Amair, and R Khanna, and B Leibel, and A Pierratos, and S Vas, and E Meema, and G Blair, and L Chisolm, and M Vas, and W Zingg, and G Digenis, and D Oreopoulos
June 1983, Israel journal of medical sciences,
P Amair, and R Khanna, and B Leibel, and A Pierratos, and S Vas, and E Meema, and G Blair, and L Chisolm, and M Vas, and W Zingg, and G Digenis, and D Oreopoulos
January 1990, Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui,
P Amair, and R Khanna, and B Leibel, and A Pierratos, and S Vas, and E Meema, and G Blair, and L Chisolm, and M Vas, and W Zingg, and G Digenis, and D Oreopoulos
April 2007, The Cochrane database of systematic reviews,
P Amair, and R Khanna, and B Leibel, and A Pierratos, and S Vas, and E Meema, and G Blair, and L Chisolm, and M Vas, and W Zingg, and G Digenis, and D Oreopoulos
March 1990, Journal of gerontological nursing,
P Amair, and R Khanna, and B Leibel, and A Pierratos, and S Vas, and E Meema, and G Blair, and L Chisolm, and M Vas, and W Zingg, and G Digenis, and D Oreopoulos
November 1986, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
P Amair, and R Khanna, and B Leibel, and A Pierratos, and S Vas, and E Meema, and G Blair, and L Chisolm, and M Vas, and W Zingg, and G Digenis, and D Oreopoulos
December 1985, Kidney international. Supplement,
P Amair, and R Khanna, and B Leibel, and A Pierratos, and S Vas, and E Meema, and G Blair, and L Chisolm, and M Vas, and W Zingg, and G Digenis, and D Oreopoulos
January 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
P Amair, and R Khanna, and B Leibel, and A Pierratos, and S Vas, and E Meema, and G Blair, and L Chisolm, and M Vas, and W Zingg, and G Digenis, and D Oreopoulos
December 2008, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
P Amair, and R Khanna, and B Leibel, and A Pierratos, and S Vas, and E Meema, and G Blair, and L Chisolm, and M Vas, and W Zingg, and G Digenis, and D Oreopoulos
November 1980, Archives of internal medicine,
Copied contents to your clipboard!